Back to search
FDAFDA · Food and drugs·Recall number D-915-2013

IRINOTECAN HYDROCHLORIDE INJECTION, 40 mg/2 mL (20 mg/mL), 2 mL Single Dose Vial, Rx only, Manufactured for: APP Pharmaceuticals, LLC, Schaumburg, IL 60173, NDC 63323-193-02, UPC 3 63323 19302 7.

Published August 28, 2013 · Recall initiated: January 22, 2013

Summary

FDA records drug Class II recall D-915-2013, published August 28, 2013 and initiated January 22, 2013. Recalling firm: Fresenius Kabi USA LLC (FK USA); Status: Terminated; Reported quantity: 23,672 vials; Lot: Lot #: 872CZ00101, Exp 12/13. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Crystallization: Active pharmaceutical ingredient is precipitating in product solution.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Fresenius Kabi USA LLC (FK USA)
Distributor
Nationwide
Lot
Lot #: 872CZ00101, Exp 12/13
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was IRINOTECAN HYDROCHLORIDE INJECTION, 40 mg/2 mL (20 mg/mL), 2 mL Single Dose Vial, Rx only, Manufactured for: APP Pharmaceuticals, LLC, Schaumburg, IL 60173, NDC 63323-193-02, UPC 3 63323 19302 7. recalled?

Yes. FDA published recall D-915-2013 on August 28, 2013. Reported hazard: Crystallization: Active pharmaceutical ingredient is precipitating in product solution.

What should I do if I have this product?

Voluntary: Firm initiated · Letter